Jack Sweeney

Dec 4, 2024 | cfothoughtleader.com | Jack Sweeney

In March 2020, as global lockdowns disrupted industries worldwide, Chris Nagy encountered a pivotal moment as CFO. Overnight, his company lost 25% of its revenue due to the closure of in-person focus group facilities. Responding swiftly, Nagy redirected resources to fast-track a shelved video conferencing product. By year-end, the initiative recovered half of the lost revenue, reflecting his capacity to navigate crises with focus and efficiency. Nagy’s strategic approach didn’t stop there.

Dec 2, 2024 | cfothoughtleader.com | Jack Sweeney

For Cyrus Lam, the aspect of the CFO role that sets it apart from all others is the weight of non-negotiable priorities. Despite years spent closely collaborating with CFOs as an investment banker, Lam tell us he quickly discovered a new level of accountability in the role. Managing cash flow and ensuring payroll, he says, are unyielding priorities. “If you can’t make payroll, that’s a big, big issue. It destroys trust,” he reflects.

Dec 1, 2024 | cfothoughtleader.com | Jack Sweeney

In this episode of Planning Aces, Jack Sweeney and Brett Knowles share insights from CFOs Sandra Wallach (Amprius Technologies), David Morris (Guardian Pharmacy Services), and David Eckstein (Vanta). The discussion explores how these finance leaders are leveraging technology, data, and collaboration to drive decision-making and value creation. Sandra Wallach (Amprius Technologies): Focuses on weekly collaboration and direct involvement to optimize supply chain and customer alignment.

Nov 13, 2024 | cfothoughtleader.com | Jack Sweeney

One of the key lessons that helped advance Jim Benson down the CFO path was one in clarity and focus during his tenure as FP&A leader for the customer service division of Compaq, freshly acquired by Hewlett-Packard. Eager to influence how the division’s performance was presented, Benson dedicated himself to crafting detailed reports and narratives.

Nov 5, 2024 | cfothoughtleader.com | Jack Sweeney

When it came to the public markets, no one can accuse David Morris and his seasoned C-suite colleagues, Fred Burke and Kendall Forbes, of being impatient. Guardian Pharmacy Services, a company they built from the ground up, recently raised $112 million in an IPO, listing on the NYSE under the symbol “GRDN.” The milestone reflects a culmination of over three decades of ever thoughtful, strategic decision making in a highly specialized market.